EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept

Yanjun Hou, Hiroaki Nitta, Zaibo Li iD

Cancers · 09.05.2023 · 15 (10) · 2664

DOI: 10.3390/cancers15102664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.05.2023. Verfasst von Yanjun Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 28659, USA. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amplification and/or overexpression of human epidermal growth factor receptor 2 (HER2) in breast cancer is associated with an adverse prognosis. The introduction of anti-HER2 targeted therapy has dramatically improved the clinical outcomes of patients with HER2-positive breast cancer. Unfortunately, a significant number of patients eventually relapse and develop distant metastasis. HER2 intratumoral heterogeneity (ITH) has been reported to be associated with poor prognosis in patients with anti-HER2 targeted therapies and was proposed to be a potential mechanism for anti-HER2 resistance. In this review, we described the current definition, common types of HER2 ITH in breast cancer, the challenge in interpretation of HER2 status in cases showing ITH and the clinical applications of anti-HER2 agents in breast cancer showing heterogeneous HER2 expression. Digital image analysis has emerged as an objective and reproducible scoring method and its role in the assessment of HER2 status with ITH remains to be demonstrated.

Schlagwörter

Stichwörter der Autor:innen

HER2breast cancerdigital imaging analysisheterogeneityimmunohistochemistry

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 28659, USA.
  • Roche Tissue Diagnostics, Tucson, AZ 85755, USA.
  • Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

ORCID-Profile: Zaibo Li

Zitieren

APA

Hou, Y., Nitta, H., & Li, Z. (2023). HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept. Cancers, 15(10), 2664. https://doi.org/10.3390/cancers15102664

Vancouver

Hou Y, Nitta H, Li Z. HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept. Cancers. 2023;15(10):2664. doi:10.3390/cancers15102664

BibTeX
@article{Hou2023,
  author = {Hou, Yanjun and Nitta, Hiroaki and Li, Zaibo},
  title = {HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {10},
  pages = {2664},
  doi = {10.3390/cancers15102664}
}
Kostenlos starten →